You are here » Home » Companies » Company Overview » Amrutanjan Health Care Ltd

Amrutanjan Health Care Ltd.

BSE: 590006 Sector: Health care
NSE: AMRUTANJAN ISIN Code: INE098F01031
BSE 00:00 | 01 Dec 888.85 -1.10
(-0.12%)
OPEN

890.70

HIGH

904.00

LOW

885.75

NSE 00:00 | 01 Dec 887.60 -1.55
(-0.17%)
OPEN

893.60

HIGH

902.95

LOW

885.00

OPEN 890.70
PREVIOUS CLOSE 889.95
VOLUME 4087
52-Week high 1025.55
52-Week low 465.00
P/E 41.17
Mkt Cap.(Rs cr) 2,595
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 890.70
CLOSE 889.95
VOLUME 4087
52-Week high 1025.55
52-Week low 465.00
P/E 41.17
Mkt Cap.(Rs cr) 2,595
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Amrutanjan Health Care Ltd. (AMRUTANJAN) - Director Report

Company director report

Your Directors have pleasure in presenting the Eighty Third (83rd) AnnualReport of the Company along with Audited Financial Statement for the year ended March312020.

1. FINANCIAL RESULTS

Your Directors are pleased to furnish below the financial results for the year ended31st March 2020.

(Rs. in Lakhs)

Particulars For the Current Year ended 31st March 2020 For the Previous Year ended 31st March 2019
Profit before Interest and Depreciation (continuing operations) 3903.43 3840.92
Less:
Interest 22.10 8.22
Depreciation and Amortization 435.94 458.04 315.97 324.19
Profit before tax 3445.39 3516.73
Provision for taxation
- Income Tax (943.00) (1023.00)
- Deferred Tax 5.94 6.04
Profit from continuing operations 2508.33 2499.77
Loss from discontinued operation after tax - (48.34)
Profit for the year 2508.33 2451.43
Add: Other comprehensive income not to be reclassified subsequently to profit or loss (net of tax) (29.37) (56.55)
Total comprehensive income for the year 2478.96 2394.88
Surplus from previous year brought forward 9144.20 7436.48
Profit for Appropriation 11623.16 9831.36
Appropriations:
Final Dividend Paid 306.92 248.46
Tax on Final dividend 63.09 51.07
Interim dividend Paid 613.84 321.54
Tax on Interim Dividend 126.18 66.09
Balance Profit Carried to Balance Sheet 10513.13 9144.20
11623.16 9831.36

Note : The Sales/revenue wherever referred in Board's Report and MDA denotes GrossSales (net sales plus taxes and discounts) unless explicitly mentioned as Net Sales.

2. STATE OF AFFAIRS:

Your Company has witnessed a 2.71% growth in turnover during the financial year 2019-20with total Gross Sales of Rs.28892.00 Lakhs as against Rs.28130.97 Lakhs during theprevious financial year.

Business Performance at a Glance - OTC & Beverage

Particulars 2019-20 2018-19 Change %
Production - Tonnes 914.21 872.07 4.83
- Kilo Ltrs 4838.68 4854.54 (0.33)
Sales Volume - Tonnes 812.97 809.68 0.41
- Kilo Ltrs 3713.95 4366.00 (14.93)
Net Sale (Rs. in Lakhs) 26147.67 25322.73 3.26
Operating EBITDA 3903.43 3840.92 1.61
(Rs. in Lakhs)
Operating EBITDA Margin(%) 14.93 15.17 (158)

3. DIVIDEND

Your Directors have declared two interim dividends for an aggregate Rs. 2.10 per equityshare of Re. 1/- each (for the year 2019-20). Details of the Interim Dividend paid are asbelow:

i. Interim Dividend:

Date of Board Meeting approving the Dividend Rate of Dividend % of Interim Dividend to Face Value Total Amount of Interim Dividend (Rs. in lakhs ) Date of Payment
1. November 7 2019 0.55 55% 160.77 November 26 2019
2. February 12 2020 1.55 155% 453.07 February 26 2020
TOTAL 2.10 210% 613.84

The Company has borne the entire dividend distribution tax of Rs. 126.18 lakhs towardsthe two interim dividends paid to the equity shareholders.

ii. Final Dividend:

The Board in its meeting held on 18th June 2020 has decided that the InterimDividends paid during the year 2019-20 have adequately covered the maximum amount ofdistributable profits available for distribution as Dividends for the year. Hence theBoard has decided not to recommend any further dividend as final dividend .

4. SHARE CAPITAL

The paid-up equity share capital as on March 31 2020 was Rs. 29230630 (29230630shares of Re. 1/- each).

Directors state that no disclosure or reporting is required in respect of the followingitems as there were no transactions on these items during the year under review:

(a) Issue of equity shares with differential rights as to dividend voting orotherwise;

(b) Issue of shares (including Sweat Equity Shares and ESOS) to employees of theCompany under any scheme.

5. DEPOSITS

During the year your Company has not accepted any deposits within the meaning ofprovisions of Chapter V (Acceptance of Deposits by Companies) of the Companies Act 2013read with the Companies (Acceptance of Deposits) Rules 2014 and was not holding anyamount under Deposit Account as on March 312020.

6. FINANCE

The Profit before tax for FY'20 was Rs. 3445.39 lakhs compared to Rs. 3468.39 lakhsfor FY'19.

The Investments Fixed Deposit Cash and Cash equivalents has grown from Rs. 8682.33lakhs (as at 31st March 2019) to Rs. 10893.91 lakhs (as at 31st March 2020).

7. PARTICULARS OF LOANS GUARANTEES OR INVESTMENTS

Details of Loans Guarantees and Investments covered under the provisions of Section186 of the Companies Act 2013 read with Companies (Meetings of Board and its Powers)Rules 2014 and details as required under Schedule V of SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 [SEBI LODR] are given below:

Particulars As on 31st March 2020 As on 31st March 2019
Loans (Secured & Unsecured) - -
Investments (Rs. in lakhs) 1820.64 1751.76
Guarantees (Rs. in lakhs) 213.24 213.24

The total amount stated above does not exceed the limit mentioned in section 186 ofCompanies Act 2013.

8. MANAGEMENT DISCUSSION AND ANALYSIS (MDA)

In terms of regulation 34 and Schedule V of the SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 (SEBI LODR) as amended from time to time theMDA capturing the performance industry trends and other material changes with respect toyour Company is presented in “ANNEXURE A” of this Report.

9. CORPORATE GOVERNANACE

Your Company has complied with the requirements of regulation 34 read with Schedule Vof the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBILODR) and the following Reports/ Certificates form part of the report :

a) The Report on Corporate Governance (“ANNEXURE B”)

b) The Certificate duly signed by the Chairman & Managing Director and ChiefFinancial Officer on the Financial Statements of the Company for the year ended March312020 as submitted to the Board of Directors at its meeting held on June 18 2020 ;

c) The declaration by the Managing Director & CEO regarding compliance by the Boardmembers and senior management personnel with the Company's Code of Conduct ;

d) The PCS Certificate on Corporate Governance

e) The PCS Certificate on Director's eligibility.

10. BUSINESS RESPONSIBILITY REPORT (BRR)

As mandated in Regulation 34(2)(f) of the SEBI (Listing Obligations & DisclosureRequirements) Amendment Regulations 2019 (SEBI LODR) the Business Responsibility Report(‘BRR') forms part of the Annual Report as ANNEXURE C. The report on the nineprinciples of the National Voluntary Guidelines on social environmental and economicresponsibilities of business as framed by the Ministry of Corporate Affairs is provided inrelevant sections of the BRR.

11. DIRECTORS KEY MANAGERIAL PERSONNEL & SENIOR MANAGERIAL PERSONNEL

(a) Retirement by Rotation

In accordance with the provisions of the Companies Act 2013 (‘ACT”) and theArticles of Association of the Company Dr. Pasumarthi S N Murthi (DIN: 00051303) Non-Executive Director retires by rotation at the upcoming Eighty Third (83rd) Annual GeneralMeeting and being eligible offers himself for reappointment.

Regulation 17(1A) of SEBI (Listing Obligations and Disclosure Requirements) (Amendment)Regulations 2018 prescribes that no listed entity shall appoint a person or continue thedirectorship of any person as a non-executive director who has attained the age of seventyfive years unless a special resolution is passed to that effect.

In compliance with the above approval / sanction of the members is being sought atthis AGM to re-appoint Dr. Pasumarthi S N Murthi (DIN 00051303) notwithstanding that hehas already attained the age of 75 years.

(b) Independent Directors :

The independent directors have affirmed that they satisfy the criteria laid down undersection 149(6) of the Companies Act 2013 (Act) and SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015.

The terms and conditions of appointment of the Independent Directors are placed on thewebsite of the Company www.amrutanjan.com. The details of familiarization programmesconducted to the Independent Directors are available at the weblinkhttps://www.amrutanjan.com/pdf/FR.pdf.

(c) Key Managerial Personnel (KMP):

Pursuant to the provisions of Section 2(51) of the Companies Act 2013 the KeyManagerial Personnel of the Company are - Mr. S Sambhu Prasad Chairman & ManagingDirector Mr. N Swaminathan Chief Financial Officer and Mr. M Srinivasan CompanySecretary. There was no change in the KMPs during the year.

12. BOARD MEETINGS

During the year Four (4) meetings of the Board of Directors were held. The completedetails of the meetings are furnished in the Corporate Governance Report. The interveninggap between any two Meetings was less than 120 days in compliance with the provisions ofSection 173(1) of the Companies Act 2013.

13. MEETING OF INDEPENDENT DIRECTORS

During the year one (1) separate meeting of Independent Directors was held. In thesaid meeting the independent directors assessed the quality quantity and timeliness offlow of information between the management and the Board and have expressed that thecurrent flow of information and contents were adequate for the Board to effectivelyperform its duties. They also reviewed the performance of the non-independent directorsand the board as a whole and the performance of the Chairperson of the Company taking intoaccount the views of Executive Director and NonExecutive Directors.

14. BOARD EVALUATION

Pursuant to the provisions of the Companies Act 2013 read with Rule 8(4) of theCompanies (Accounts) Rules 2014 and SEBI LODR the Board of Directors during the yearcarried out an annual performance evaluation of its own performance the directorsindividually (without participation of the relevant director) and the Chairman.

The evaluation was carried through a structured methodology approved by the Nominationand Remuneration Committee. The criteria for performance evaluation have been detailed inthe Corporate Governance Report.

The outcome of the evaluation also forms the basis for the Nomination and RemunerationCommittee while considering the appointment/re-appointment of Directors.

15. REMUNERATION POLICY

The Remuneration policy of the Company deals with the appointment of and remunerationto the Executive & Nonexecutive Directors Key Managerial Personnel and SeniorExecutives of the Company including criteria for determining qualifications positiveattributes independence of a Director and other related matters. It aims to attractrecruit and retain exceptional talent and ensures that the remuneration is performancedriven. The Policy has been provided in the website of the Company -https://www.amrutanjan.com/policy.html. The Nomination and Remuneration Committee has alsoframed a Policy on Board diversity appropriate to the business requirements of theCompany which inter-alia specifies optimum combination of Executive DirectorsNon-Executive Directors and Independent Directors the recommendatory requirement for eachof the directors to possess functional diversity and role of Nomination and RemunerationCommittee to ensure that the Policy on Board diversity is considered while recommendingthe appointment of new directors on the Board of the company.

The details of remuneration paid / payable to the directors during the financial year2019-20 are furnished in the Corporate Governance report annexed to this report.

16. VIGIL MECHANISM/ WHISTLE BLOWER POLICY

Pursuant to Section 177(9) of the Companies Act 2013 read with Rule 7 of the Companies(Meetings of Board and its Powers) Rules 2014 and Regulation 22 of the SEBI (ListingObligations & Disclosure Requirements) Regulations 2015 the Board of Directors hadapproved the Policy on Vigil Mechanism/ Whistle Blower and the same was further amendedeffective from 1st April 2019 to comply with the amended SEBI Insider TradingRegulations. The Policy is hosted on the website of the Companyhttps://www.amrutanjan.com/pdf/Whistle%20Blower%20Poli cy.pdf .

The Policy inter-alia provides direct access to the Chairman of the Audit Committee.

Your Company hereby affirms that no Director/ employee have been denied access to theChairman of the Audit Committee and that no complaints were received during the year.

17. UNCLAIMED SHARES

The details of unclaimed shares held in Unclaimed Shares Suspense Account pursuant toSEBI LODR are provided in the Corporate Governance Report.

18. STATUTORY AUDITORS & THEIR REPROT

M/s. B S R & Co. LLP Chartered Accountants (ICAI Firm Registration No.101248W/W-100022) were appointed as Statutory Auditors at the conclusion of Eightieth(80th) AGM held on September 21 2017 for a period of five (5) years till the conclusionof the Eighty Fifth (85th) Annual General Meeting of the Company. Pursuant to thenotification dated May 7 2018 of the relevant provisions of the Companies (Amendment)Act 2017 and Rule 3 of the Companies (Audit and Auditors) Rules 2018 the ratificationof statutory auditor appointed in the AGM for five years is dispensed with.

The Statutory Auditors' report to the shareholders on the financials for the year endedMarch 31 2020 does not contain any qualification observation or adverse comment.

19. SECRETARIAL AUDITOR & AUDIT REPORT

Pursuant to the provisions of Section 204 of the Companies Act 2013 read with theCompanies (Appointment and Remuneration of Managerial Personnel) Rules 2014 the Companyhas appointed M/s P Sriram & Associates Practicing Company Secretaries as itssecretarial auditor to undertake the secretarial audit for FY 2019-20 The secretarialaudit report certified by the secretarial auditors in the specified form MR-3 is annexedherewith and forms part of this report “Annexure E”.

The secretarial audit report does not contain any qualifications reservations oradverse remarks or disclaimer.

20. COST AUDITOR

Pursuant to Section 148 of the Companies Act 2013 read with the Companies (CostRecords and Audit) Rules 2014 the Board of Directors at its meeting held on August 132020 has appointed Mr. G Thangaraj (Registration No. 100464) Cost Accountant as the CostAuditor to conduct the cost audit with respect to OTC business of the company for thefinancial year ending March 31 2021. He was also the cost auditor for the previous yearended March 312020.

21. CORPORATE SOCIAL RESPONSIBILITY (CSR) INITIATIVES

The CSR activities carried out by your Company during the financial year 2019-20 weremainly focused on (a) Animal Welfare (b) Health and Sanitation (c) Promoting Education (d)Assistance in COVID-19 pandemic (e) Empowerment of Women. The activities undertaken by theCompany are in accordance with Schedule VII of the Companies Act 2013 the CSR Policy ofthe Company and as per recommendations of the CSR Committee.

The CSR Committee met twice (2) during the year to oversee the activities programs andexecution of initiatives as per the predetermined guidelines of the Board and approve theamount to be spent towards CSR. The Board takes pleasure to inform that the Company hasspent the entire amount that was mandatorily to be incurred towards the CSR spends for theyear 2019-20.

The main objectives of CSR policy of the Company are to help build socio-economicdevelopment of the nation through different projects and to ensure environmentalsustainability. The Policy has widened scope to undertake all activities permitted underlaw. The CSR Policy is available on the website of the Company at the web-linkhttps://www.amrutanjan.com/pdf/ahcl-csr-policy.pdf. The detailed report on CSR activitiescarried out during the financial year is given in “ANNEXURE D”.

22. PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES

Disclosures pertaining to remuneration and other details as required under Section197(12) of the Companies Act 2013 read with Rule 5(2) of the Companies (Appointment andRemuneration of Managerial Personnel) Rules 2014 are provided in “ANNEXURE F”.

23. EXTRACT OF ANNUAL RETURN

An extract of Annual Return in Form MGT-9 as on March 312020 as per provisions ofSection 92(3) of the Companies Act 2013 is attached as "ANNEXURE G" to thisReport. Also pursuant to Section 134(3) of Companies Act 2013 a copy of Annual return ofthe Company is available on the website of the Company at the web-linkhttps://www.amrutanjan.com/Annualreturn.html.

24. RELATED PARTY TRANSACTIONS

No material significant related party transaction was made by the Company during theyear with Promoters Directors Key Managerial Personnel or other designated persons whichmay have a potential conflict with the interest of the Company at large and accordinglyapplicability of Form AOC-2 does not exist.

25. CONSERVATION OF ENERGY/TECHNOLOGY ABSORPTION AND FOREIGN EARNINGS/OUTGO

Information as required under Section 134(3)(m) of the Companies Act 2013 read withRule 8(3) of the Companies (Accounts) Rules 2014 relating to Conservation of EnergyTechnology Absorption Foreign Exchange Earnings and Outgo are furnished in “ANNEXUREH” to this Report.

26. DIRECTORS' RESPONSIBILITY STATEMENT

To the best of their knowledge and belief and according to the information andexplanations obtained by them your Directors make the following statements in terms ofSection 134(3)(c) & 134(5) of the Companies Act 2013:

I. that in the preparation of the annual financial statements for the year ended March31 2020 the applicable accounting standards had been followed along with properexplanation relating to material departures;

II. that the directors had selected such accounting policies and applied themconsistently and had made judgment and estimates that are reasonable and prudent so as togive a true and fair view of the state of affairs of the Company as at March 312020 andof the profit of the Company for the year ended on that date;

III. that proper and sufficient care has been taken for the maintenance of adequateaccounting records in accordance with the provisions of the Companies Act 2013 forsafeguarding the assets of the Company and for preventing and detecting fraud and otherirregularities;

IV. that the annual financial statements have been prepared on a going concern basis;

V. that proper internal financial controls were followed by the Company and that suchinternal financial controls are adequate and were operating effectively.

VI. That proper systems had been devised to ensure compliance with the provisions ofall applicable laws and that such systems are adequate and operating effectively.

27. INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY

The Company has a proper and adequate internal control system to ensure that all theassets of the Company are safeguarded and protected against any loss and that all thetransactions are properly authorised and recorded. Information provided to management isreliable and timely. Details of the same are provided in the Management Discussion andAnalysis Report.

28. ENVIRONMENTAL SAFETY AND HEALTH

Your Company is committed to ensure sound Safety Health and Environmental (SHE)performance related to its activities products and services. The Company is takingcontinuous steps to develop Safer Process Technologies and Unit Operations. Your Companyhas been investing heavily in areas such as Process Automation for increased safety andreduction of human error element. Enhanced level of training on Process and Behavior basedsafety adoption of safe & environmental friendly production process ManagementSystem is done on a continuous basis. The Company is committed to continuously takefurther steps to provide a safe and healthy environment.

29. RISK MANAGEMENT POLICY :

Your Company has a Risk Management Policy adopted by the Board. Periodical in-houserisk audits were conducted to detect and mitigate the risks in a timely and effectivemanner. Management Discussion and Analysis Report contain more details on the riskmanagement practiced by the Company.

30. MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY

There were no material changes and commitments affecting the financial position of theCompany between the closure of the financial year 2019-20 and the date of this report.

31. SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS

There are no significant and material orders passed by the Regulators or Courts orTribunals which would impact the going concern status of the Company.

32. ENHANCING SHAREHOLDERS VALUE

Your Company believes that its Members are among its most important stakeholders.Accordingly your Company's operations are committed to the pursuit of achieving highlevels of operating performance and cost competitiveness consolidating and building forgrowth enhancing the productive asset and resource base and nurturing overall corporatereputation. Your Company is also committed to creating value for its other stakeholders byensuring that its corporate actions positively impact the socio-economic and environmentaldimensions and contribute to sustainable growth and development.

33. PREVENTION OF SEXUAL HARASSMENT POLICY

The Company has in place a Prevention of Sexual Harassment policy in line with therequirements of the Sexual Harassment of Women at the Workplace (Prevention Prohibitionand Redressal) Act 2013. An Internal Complaints Committee has been set up to redresscomplaints received regarding sexual harassment. All employees (permanent contractualtemporary trainees) are covered under this policy.

During the year 2019-20 no complaints were received by the Company related to sexualHarassment.

34. ACKNOWLEDGEMENT

The Directors wish to express their sincere appreciation to all the GovernmentDepartments Bankers Customers Distributors Suppliers and the shareholders for theirco-operation and support extended during the year.

The Directors also wish to thank all the employees for their contribution support andcontinued commitment throughout the year.

By Order of the Board
For and on behalf of the Board
Place : Chennai S Sambhu Prasad
Date : June 18 2020 Chairman and Managing Director
Registered Office:
Amrutanjan Health Care Limited
CIN:L24231TN1936PLC000017
No.103 Luz Church Road Mylapore Chennai 600 004
Tel : 044-2499 4465 Fax : 044-2499 4585
Email : shares@amrutanjan.com
Website : www.amrutanjan.com

.